The Horseracing Integrity & Welfare Unit (HIWU), which was established by Drug Free Sport International to administer the Horseracing Integrity and Safety Authority's (HISA) Anti-Doping and Medication Control (ADMC) Program, has named Dr. Mary Scollay as its chief of science.
In this role, which she commences Oct. 10, Scollay will oversee HIWU's Science Department, including the HISA Equine Analytical Laboratory accreditation program, and education efforts ahead of the ADMC Program launch in January 2023. She will also prioritize research development into Prohibited Substances while engaging with veterinary scientists, pharmacologists, and other experts in the Thoroughbred industry. Additionally, Scollay and her team will manage a Prohibited Substances database that will be available for industry stakeholders to use as a reference tool.
Scollay joins HIWU after serving as the Racing Medication & Testing Consortium's (RMTC) executive director and chief operating officer for three years. While with the RMTC, she directed the advancement of world-class laboratory drug testing standards, promotion of RMTC-recommended rules and penalties for prohibited substances and therapeutic medications, monitoring of emerging threats to the integrity of racing and the health and welfare of racehorses, and administrative oversight of RMTC-funded research projects and educational programs.
Before leading the RMTC, Scollay spent more than 30 years as a racing regulatory veterinarian, including 11 years as the Kentucky Horse Racing Commission's equine medical director.
“Dr. Scollay's extensive experience in the areas of anti-doping rules, testing standards, and veterinary regulation in the Thoroughbred industry will make her a key asset to HIWU,” said Ben Mosier, executive director of HIWU. “We are fortunate to retain her knowledge and skillset as we prepare for the implementation of the ADMC Program on January 1, 2023.”
Named to HISA's ADMC Standing Committee in May 2021, Scollay has resigned from that responsibility to take on her position with HIWU.
“HISA represents the way forward for Thoroughbred racing, the only way forward,” said Scollay. “I am grateful for the opportunity to continue serving the sport during this transition, and I am committed to working with HIWU to deliver a best-in-class equine anti-doping program to the industry.”
Not a subscriber? Click here to sign up for the daily PDF or alerts.
